Passage BIO, Inc. - PASG

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$18.6M
QoQ value delta ($000)
+$6.046M (+48.16%)
Implied price effect (QoQ)
+46.87%
Shares
Total shares
1,577,414
QoQ shares delta
+13,721 (+0.88%)
Total shares held by funds (by quarter)

Market chart (PASG)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
Lynx1 Capital Management LP 7,359 623,704 1.49%
Vestal Point Capital, LP 3,599 305,000 0.12%
VANGUARD GROUP INC 1,494 126,645 0.0%
Eversept Partners, LP 1,489 126,230 0.08%
RENAISSANCE TECHNOLOGIES LLC 1,287 109,089 0.0%
Erste Asset Management GmbH 1,004 85,262 0.01%
Yiheng Capital Management, L.P. 404 34,301 0.08%
GEODE CAPITAL MANAGEMENT, LLC 370 31,397 0.0%
BlackRock, Inc. 341 28,903 0.0%
ACADIAN ASSET MANAGEMENT LLC 284 24,196 0.0%
CITADEL ADVISORS LLC 208 17,660 0.0%
NORTHERN TRUST CORP 167 14,217 0.0%
Quadrature Capital Ltd 148 12,578 0.0%
Squarepoint Ops LLC 127 10,799 0.0%
FIDUCIARY TRUST CO 126 10,750 0.0%
NANO CAP NEW MILLENNIUM GROWTH FUND L P 118 10,000 0.1%
MORGAN STANLEY 50 4,275 0.0%
UBS Group AG 17 1,442 0.0%
Rockefeller Capital Management L.P. 5 500 0.0%
BARCLAYS PLC 2 212 0.0%
SBI Securities Co., Ltd. 1 142 0.0%
JPMORGAN CHASE & CO 0 15 0.0%
BANK OF AMERICA CORP /DE/ 0 28 0.0%
HARBOUR INVESTMENTS, INC. 0 3 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 12 0.0%